Literature DB >> 2751093

An endpoint enzymatic assay for fructose 2,6-bisphosphate performed in 96-well plates.

P Bruni1, V Vasta, M Farnararo.   

Abstract

An endpoint enzymatic assay for fructose 2,6-bisphosphate based on the ability of the compound to stimulate pyrophosphate 6-phosphofructo-1-kinase and performed in a 96-well plate is reported here. The method presents a low detection limit and a high sensitivity that could be further improved; moreover, the use of 96-well plates greatly increases the number of samples that can be simultaneously assayed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2751093     DOI: 10.1016/0003-2697(89)90646-5

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  3 in total

1.  Activation of p53 enhances apoptosis and insulin resistance in a rat model of alcoholic liver disease.

Authors:  Zoltan Derdak; Charles H Lang; Kristine A Villegas; Ming Tong; Nicholas M Mark; Suzanne M de la Monte; Jack R Wands
Journal:  J Hepatol       Date:  2010-09-06       Impact factor: 25.083

2.  Control of glycolysis in cultured chick embryo hepatocytes. Fructose 2,6-bisphosphate content and phosphofructokinase-1 activity are stimulated by insulin and epidermal growth factor.

Authors:  M J Hamer; A J Dickson
Journal:  Biochem J       Date:  1990-08-01       Impact factor: 3.857

3.  Fructose 2,6-bisphosphate metabolism during megakaryocytic differentiation of K562 and MEG-01 cells.

Authors:  E Meacci; V Vasta; M Farnararo; P Bruni
Journal:  Mol Cell Biochem       Date:  1996-03-23       Impact factor: 3.396

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.